Zhejiang Haisen Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -9.54% vs 2.33% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -7.37% vs -6.59% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "107.20",
          "val2": "118.50",
          "chgp": "-9.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.00",
          "val2": "37.30",
          "chgp": "-14.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.90",
          "val2": "31.20",
          "chgp": "-7.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "298.80%",
          "val2": "273.40%",
          "chgp": "2.54%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.11% vs 18.74% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 10.85% vs 17.10% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "529.70",
          "val2": "468.30",
          "chgp": "13.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "166.30",
          "val2": "133.70",
          "chgp": "24.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "135.90",
          "val2": "122.60",
          "chgp": "10.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "269.20%",
          "val2": "249.20%",
          "chgp": "2.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

107.20

118.50

-9.54%

Operating Profit (PBDIT) excl Other Income

32.00

37.30

-14.21%

Interest

0.10

0.10

Exceptional Items

0.00

0.00

Consolidate Net Profit

28.90

31.20

-7.37%

Operating Profit Margin (Excl OI)

298.80%

273.40%

2.54%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -9.54% vs 2.33% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -7.37% vs -6.59% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

529.70

468.30

13.11%

Operating Profit (PBDIT) excl Other Income

166.30

133.70

24.38%

Interest

0.60

0.60

Exceptional Items

1.80

0.00

Consolidate Net Profit

135.90

122.60

10.85%

Operating Profit Margin (Excl OI)

269.20%

249.20%

2.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 13.11% vs 18.74% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 10.85% vs 17.10% in Dec 2024

All Annual Results